UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000035556
Receipt number R000037174
Scientific Title Utility of the probiotics on the postoperative course of the open heart surgery in children
Date of disclosure of the study information 2019/01/16
Last modified on 2024/01/19 19:19:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Utility of the probiotics on the postoperative course of the open heart surgery in children

Acronym

Utility of the probiotics on the postoperative course of the open heart surgery in children

Scientific Title

Utility of the probiotics on the postoperative course of the open heart surgery in children

Scientific Title:Acronym

Utility of the probiotics on the postoperative course of the open heart surgery in children

Region

Japan


Condition

Condition

Congenital heart disease with biventricular anatomy

Classification by specialty

Cardiovascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effect of probiotics (BBG-01) on intestinal microflora ,intestinal permeability, and surgical outcome, after open heart surgery in children

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

changes in fecal microflora
changes in blood microflora

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking

YES

Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

BBG-01 administration

Interventions/Control_2

BBG-01 non-administration

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit

15 years-old >=

Gender

Male and Female

Key inclusion criteria

1.Patients who underwent open heart surgery
2.Child(0-15 years old)
3.Cases in which written informed consent was obtained from the substitute

Key exclusion criteria

1.Emergency case
2.Univentricular heart
3.Fontan candidate
4. Cases who died in 7 days after surgery
5. Cases who could not take BBG-01 for 7 days before surgery
6.Allegy for milk, potato, and corn
7.Associated with gastrointestinal disease
8. Cases in which the doctor judged that the registration in this study is inappropriate

Target sample size

80


Research contact person

Name of lead principal investigator

1st name DAISUKE
Middle name
Last name TORITSUKA

Organization

University of Toyama

Division name

Department of Thoracic and Cardiovascular Surgery

Zip code

9300194

Address

2630 Sugitani,Toyama,Toyama

TEL

076-434-7330

Email

dtoritsuka@gmail.com


Public contact

Name of contact person

1st name DAISUKE
Middle name
Last name TORITSUKA

Organization

University of Toyama

Division name

Department of Thoracic and Cardiovascular Surgery

Zip code

9300194

Address

2630 Sugitani,Toyama,Toyama

TEL

076-434-7330

Homepage URL


Email

black11@med.u-toyama.ac.jp


Sponsor or person

Institute

University of Toyama

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

The Yakult Central Institute, Yakult Honsha Co, Ltd., Tokyo, Japan

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Toyama university hospital Center for clinical research

Address

2630 Sugitani,Toyama,Toyama

Tel

076-415-8857

Email

rinri@adm.u-toyama.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

富山大学病院(富山県)


Other administrative information

Date of disclosure of the study information

2019 Year 01 Month 16 Day


Related information

URL releasing protocol

no

Publication of results

Partially published


Result

URL related to results and publications

no

Number of participants that the trial has enrolled

82

Results

The total number of obligate anaerobes was higher in the intervention group after post operative day7.
Facal organic acids did not differ between the two groups, but were decreased by the surgery
Bacterial translocation occurred in about 40% of both groups.
I-FABP did not differ between the two groups, but were elevated in the early postoperative period.
Inflammation markers except IL-17A did not differ between the two groups

Results date posted

2024 Year 01 Month 19 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Patient background did not differ between the two groups, and there were no perioperative deaths.

Participant flow

The patients were randomly allocated to two groups: the intervention group (IG) (n=41) received BBG-01 after every meal 3 times a day every 7 days just before surgery and from post-operative day 1 to discharge, and the control group (CG) (n=41) did not receive BBG-01 treatment. All patients received perioperative antibiotic prophylaxis from the day of surgery until postoperative day 2

Adverse events

No adverse events

Outcome measures

Fecal microbiota
Measurements of fecal organic acid concentrations and pH
Blood microbiota
I-FABP levels
Blood cell counts, lymphocyte subsets, and plasma cytokine and inflammation biomarker

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2018 Year 12 Month 19 Day

Date of IRB

2018 Year 06 Month 18 Day

Anticipated trial start date

2019 Year 01 Month 17 Day

Last follow-up date

2020 Year 12 Month 31 Day

Date of closure to data entry

2021 Year 05 Month 17 Day

Date trial data considered complete

2021 Year 05 Month 17 Day

Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 01 Month 16 Day

Last modified on

2024 Year 01 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000037174


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name